Literature DB >> 31925808

Intravenous methotrexate at a dose of 1 g/m2 incorporated into RCHOP prevented CNS relapse in high-risk DLBCL patients: A prospective, historic controlled study.

Wei Wang1, Yan Zhang1, Lu Zhang1, Chen Yang1, Jun Feng1, Huacong Cai1, Miao Chen1, Xinxin Cao1, Junling Zhuang1, Tienan Zhu1, Minghui Duan1, Wei Zhang1, Jian Li1, Daobin Zhou1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31925808     DOI: 10.1002/ajh.25723

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  1 in total

1.  Prospective evaluation of high-dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function.

Authors:  Jason N Barreto; Joel M Reid; Carrie A Thompson; Kristin C Mara; Andrew D Rule; Kianoush B Kashani; Nelson Leung; Thomas R Larson; Renee M McGovern; Thomas E Witzig; Erin F Barreto
Journal:  Clin Transl Sci       Date:  2021-08-23       Impact factor: 4.689

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.